Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$4.51 USD
-0.03 (-0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.53 +0.02 (0.44%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.51 USD
-0.03 (-0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.53 +0.02 (0.44%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth C Momentum D VGM
Zacks News
Medical Properties (MPW) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Medical Properties (MPW) stood at $4.80, denoting a -0.21% change from the preceding trading day.
Medical Properties (MPW) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $4.81, marking no change from the previous day.
Here is What to Know Beyond Why Medical Properties Trust, Inc. (MPW) is a Trending Stock
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is Trending Stock Medical Properties Trust, Inc. (MPW) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Medical Properties (MPW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's What Key Metrics Tell Us About Medical Properties (MPW) Q1 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Medical Properties (MPW) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Medical Properties (MPW) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of -4% and 4.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Innovative Industrial Properties (IIPR) Q1 FFO and Revenues Miss Estimates
by Zacks Equity Research
Innovative Industrial Properties (IIPR) delivered FFO and revenue surprises of -2.64% and 5.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Medical Properties (MPW) in Q1 Earnings?
by Zacks Equity Research
While Medical Properties' (MPW) Q1 earnings are likely to have benefited from the favorable healthcare industry trends, the high interest rate environment may have hurt it.
Global Net Lease (GNL) Matches Q1 FFO Estimates
by Zacks Equity Research
Global Net Lease (GNL) delivered FFO and revenue surprises of 0% and 0.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings
by Zacks Equity Research
With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investments in such properties are likely to have aided its Q1 performance, though high expenses might have played a spoilsport.
What's in Store for Gladstone Commercial (GOOD) in Q1 Earnings?
by Zacks Equity Research
Gladstone Commercial's (GOOD) Q1 results are likely to reflect the benefits of its premium facilities at strategic locations and expansion efforts, though high supply might partly limit the growth tempo
What's in the Offing for Realty Income (O) in Q1 Earnings?
by Zacks Equity Research
Healthy demand for Realty Income's (O) properties and a diverse tenant base are likely to have benefited the company's Q1 earnings, though higher interest expenses might have been a dampener.
What's in Store for Simon Property (SPG) This Earnings Season?
by Zacks Equity Research
While Simon Property (SPG) is poised to benefit from its efforts to support omnichannel retailing and solid balance sheet strength, high interest rates are likely to have acted as a spoilsport.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why the Market Dipped But Medical Properties (MPW) Gained Today
by Zacks Equity Research
Medical Properties (MPW) reachead $4.63 at the closing of the latest trading day, reflecting a +0.65% change compared to its last close.
VICI Properties Inc. (VICI) Q1 FFO Match Estimates
by Zacks Equity Research
VICI Properties (VICI) delivered FFO and revenue surprises of 0% and 0.98%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Vornado (VNO) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Healthy demand for Vornado's (VNO) premium office assets is likely to have benefited its Q1 performance. However, higher interest expenses are anticipated to have hurt it.
Regency Centers (REG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers and strategic acquisitions are likely to have benefited the company's Q1 earnings. However, higher interest rates might have ailed.
What's in Store for Federal Realty (FRT) This Earnings Season?
by Zacks Equity Research
Federal Realty's (FRT) first-quarter results are likely to gain from the healthy leasing activity, though tenant bankruptcies and higher interest expenses act as dampeners.
Digital Realty (DLR) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Solid data center demand and acceleration in digital transformation strategies are likely to have aided Digital Realty's (DLR) Q1 earnings. However, high interest expenses may have ailed.
What's in the Cards for Kimco (KIM) This Earnings Season?
by Zacks Equity Research
While a healthy retail real estate market and focus on developing mixed-use assets are likely to have aided Kimco's (KIM) Q1 earnings, higher interest expenses may have hurt it.
Wall Street's Insights Into Key Metrics Ahead of Medical Properties (MPW) Q1 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Medical Properties (MPW) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Medical Properties (MPW) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $4.09, representing a -0.49% change from its previous close.
Medical Properties (MPW) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $4.25, representing a -1.39% change from its previous close.